DHEA Peptide vs Lanreotide
Overview
DHEA Peptide and Lanreotide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares DHEA Peptide and Lanreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| DHEA Peptide | Lanreotide | |
|---|---|---|
| Category | Hormonal | Hormonal |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | 25-50 mg | 60-120 mg |
| Frequency | daily | every 4 weeks |
| Reported benefits | Hormone balance, energy, anti-aging | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones |
| Reported side effects | Possible acne, hormone fluctuations | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases |
Key differences
Primary use. DHEA Peptide is categorised under Hormonal, while Lanreotide falls under Hormonal. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. DHEA Peptide: not FDA-approved; treated as a research compound. Lanreotide: FDA-approved.
Dosing. DHEA Peptide is typically dosed at 25-50 mg (daily). Lanreotide is typically dosed at 60-120 mg (every 4 weeks).
Can you stack them?
Some protocols combine peptides, but stacking DHEA Peptide and Lanreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between DHEA Peptide and Lanreotide?
- DHEA Peptide and Lanreotide are both hormonal peptides, but they differ in mechanism, dosing, and regulatory status. DHEA Peptide is not FDA-approved; generally classified as a research compound, whereas Lanreotide is FDA-approved for one or more indications.
- What is DHEA Peptide used for?
- Hormone precursor support.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- Can you take DHEA Peptide and Lanreotide together?
- Some users combine peptides within a single protocol, but stacking DHEA Peptide and Lanreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is DHEA Peptide or Lanreotide FDA-approved?
- DHEA Peptide is not FDA-approved; generally classified as a research compound. Lanreotide is FDA-approved for one or more indications.
Read the full articles
- DHEA Peptide — full monograph: mechanism, research, dosing & references
- Lanreotide — full monograph: mechanism, research, dosing & references